nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—CYP1A2—Diphenhydramine—atopic dermatitis	0.0852	0.232	CbGbCtD
Dexmedetomidine—CYP2D6—Loratadine—atopic dermatitis	0.0702	0.191	CbGbCtD
Dexmedetomidine—CYP2D6—Diphenhydramine—atopic dermatitis	0.0702	0.191	CbGbCtD
Dexmedetomidine—CYP1A1—Dexamethasone—atopic dermatitis	0.066	0.18	CbGbCtD
Dexmedetomidine—CYP2E1—Dexamethasone—atopic dermatitis	0.0509	0.139	CbGbCtD
Dexmedetomidine—CYP2D6—Dexamethasone—atopic dermatitis	0.0243	0.0662	CbGbCtD
Dexmedetomidine—Abdominal pain—Mometasone—atopic dermatitis	0.000798	0.00132	CcSEcCtD
Dexmedetomidine—Body temperature increased—Mometasone—atopic dermatitis	0.000798	0.00132	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.000793	0.00131	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Dexamethasone—atopic dermatitis	0.000793	0.00131	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Betamethasone—atopic dermatitis	0.000793	0.00131	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Prednisolone—atopic dermatitis	0.000789	0.0013	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Prednisolone—atopic dermatitis	0.000789	0.0013	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Tacrolimus—atopic dermatitis	0.000787	0.0013	CcSEcCtD
Dexmedetomidine—Tachycardia—Tacrolimus—atopic dermatitis	0.000784	0.0013	CcSEcCtD
Dexmedetomidine—Dizziness—Loratadine—atopic dermatitis	0.000778	0.00129	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.000777	0.00128	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.000775	0.00128	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.000771	0.00127	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Hydrocortisone—atopic dermatitis	0.000771	0.00127	CcSEcCtD
Dexmedetomidine—Hypotension—Tacrolimus—atopic dermatitis	0.000751	0.00124	CcSEcCtD
Dexmedetomidine—Vomiting—Loratadine—atopic dermatitis	0.000748	0.00124	CcSEcCtD
Dexmedetomidine—Rash—Loratadine—atopic dermatitis	0.000742	0.00123	CcSEcCtD
Dexmedetomidine—Dermatitis—Loratadine—atopic dermatitis	0.000741	0.00123	CcSEcCtD
Dexmedetomidine—Headache—Loratadine—atopic dermatitis	0.000737	0.00122	CcSEcCtD
Dexmedetomidine—Bradycardia—Prednisolone—atopic dermatitis	0.000736	0.00122	CcSEcCtD
Dexmedetomidine—Sweating increased—Betamethasone—atopic dermatitis	0.000734	0.00121	CcSEcCtD
Dexmedetomidine—Sweating increased—Dexamethasone—atopic dermatitis	0.000734	0.00121	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.00073	0.00121	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.000728	0.0012	CcSEcCtD
Dexmedetomidine—Haemoglobin—Prednisolone—atopic dermatitis	0.000726	0.0012	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Triamcinolone—atopic dermatitis	0.000726	0.0012	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Triamcinolone—atopic dermatitis	0.000726	0.0012	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Methylprednisolone—atopic dermatitis	0.000724	0.0012	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.000724	0.0012	CcSEcCtD
Dexmedetomidine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000724	0.0012	CcSEcCtD
Dexmedetomidine—Haemorrhage—Prednisolone—atopic dermatitis	0.000723	0.00119	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Prednisone—atopic dermatitis	0.000722	0.00119	CcSEcCtD
Dexmedetomidine—Bradycardia—Hydrocortisone—atopic dermatitis	0.000718	0.00119	CcSEcCtD
Dexmedetomidine—Dyspnoea—Tacrolimus—atopic dermatitis	0.000717	0.00118	CcSEcCtD
Dexmedetomidine—Somnolence—Tacrolimus—atopic dermatitis	0.000714	0.00118	CcSEcCtD
Dexmedetomidine—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000709	0.00117	CcSEcCtD
Dexmedetomidine—Haemorrhage—Hydrocortisone—atopic dermatitis	0.000706	0.00117	CcSEcCtD
Dexmedetomidine—Hallucination—Hydrocortisone—atopic dermatitis	0.000702	0.00116	CcSEcCtD
Dexmedetomidine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000699	0.00116	CcSEcCtD
Dexmedetomidine—Nausea—Loratadine—atopic dermatitis	0.000699	0.00116	CcSEcCtD
Dexmedetomidine—Visual impairment—Prednisolone—atopic dermatitis	0.000696	0.00115	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000694	0.00115	CcSEcCtD
Dexmedetomidine—Diarrhoea—Mometasone—atopic dermatitis	0.000691	0.00114	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Prednisone—atopic dermatitis	0.000691	0.00114	CcSEcCtD
Dexmedetomidine—Constipation—Tacrolimus—atopic dermatitis	0.000687	0.00114	CcSEcCtD
Dexmedetomidine—Pain—Tacrolimus—atopic dermatitis	0.000687	0.00114	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Dexamethasone—atopic dermatitis	0.000679	0.00112	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Betamethasone—atopic dermatitis	0.000679	0.00112	CcSEcCtD
Dexmedetomidine—Bradycardia—Triamcinolone—atopic dermatitis	0.000676	0.00112	CcSEcCtD
Dexmedetomidine—Bradycardia—Methylprednisolone—atopic dermatitis	0.000675	0.00112	CcSEcCtD
Dexmedetomidine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000672	0.00111	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.000669	0.00111	CcSEcCtD
Dexmedetomidine—Haemoglobin—Triamcinolone—atopic dermatitis	0.000668	0.0011	CcSEcCtD
Dexmedetomidine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000667	0.0011	CcSEcCtD
Dexmedetomidine—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000666	0.0011	CcSEcCtD
Dexmedetomidine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000666	0.0011	CcSEcCtD
Dexmedetomidine—Haemorrhage—Triamcinolone—atopic dermatitis	0.000664	0.0011	CcSEcCtD
Dexmedetomidine—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000663	0.0011	CcSEcCtD
Dexmedetomidine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000662	0.0011	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000662	0.0011	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000662	0.00109	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000662	0.00109	CcSEcCtD
Dexmedetomidine—Abdominal distension—Prednisone—atopic dermatitis	0.00066	0.00109	CcSEcCtD
Dexmedetomidine—Hallucination—Methylprednisolone—atopic dermatitis	0.00066	0.00109	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Betamethasone—atopic dermatitis	0.000658	0.00109	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Dexamethasone—atopic dermatitis	0.000658	0.00109	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Dexamethasone—atopic dermatitis	0.000658	0.00109	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Betamethasone—atopic dermatitis	0.000658	0.00109	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000657	0.00109	CcSEcCtD
Dexmedetomidine—Arrhythmia—Prednisolone—atopic dermatitis	0.000645	0.00107	CcSEcCtD
Dexmedetomidine—Vomiting—Mometasone—atopic dermatitis	0.000642	0.00106	CcSEcCtD
Dexmedetomidine—Sweating increased—Prednisone—atopic dermatitis	0.000639	0.00106	CcSEcCtD
Dexmedetomidine—Visual impairment—Methylprednisolone—atopic dermatitis	0.000639	0.00106	CcSEcCtD
Dexmedetomidine—Rash—Mometasone—atopic dermatitis	0.000637	0.00105	CcSEcCtD
Dexmedetomidine—Dermatitis—Mometasone—atopic dermatitis	0.000636	0.00105	CcSEcCtD
Dexmedetomidine—Abdominal pain—Tacrolimus—atopic dermatitis	0.000635	0.00105	CcSEcCtD
Dexmedetomidine—Body temperature increased—Tacrolimus—atopic dermatitis	0.000635	0.00105	CcSEcCtD
Dexmedetomidine—Headache—Mometasone—atopic dermatitis	0.000633	0.00105	CcSEcCtD
Dexmedetomidine—Arrhythmia—Hydrocortisone—atopic dermatitis	0.00063	0.00104	CcSEcCtD
Dexmedetomidine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000628	0.00104	CcSEcCtD
Dexmedetomidine—Mental disorder—Hydrocortisone—atopic dermatitis	0.000618	0.00102	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000615	0.00102	CcSEcCtD
Dexmedetomidine—Malnutrition—Hydrocortisone—atopic dermatitis	0.000614	0.00102	CcSEcCtD
Dexmedetomidine—Bradycardia—Betamethasone—atopic dermatitis	0.000614	0.00101	CcSEcCtD
Dexmedetomidine—Bradycardia—Dexamethasone—atopic dermatitis	0.000614	0.00101	CcSEcCtD
Dexmedetomidine—Haemoglobin—Betamethasone—atopic dermatitis	0.000606	0.001	CcSEcCtD
Dexmedetomidine—Haemoglobin—Dexamethasone—atopic dermatitis	0.000606	0.001	CcSEcCtD
Dexmedetomidine—Haemorrhage—Dexamethasone—atopic dermatitis	0.000603	0.000997	CcSEcCtD
Dexmedetomidine—Haemorrhage—Betamethasone—atopic dermatitis	0.000603	0.000997	CcSEcCtD
Dexmedetomidine—Angiopathy—Methylprednisolone—atopic dermatitis	0.000602	0.000995	CcSEcCtD
Dexmedetomidine—Hallucination—Dexamethasone—atopic dermatitis	0.0006	0.000992	CcSEcCtD
Dexmedetomidine—Hallucination—Betamethasone—atopic dermatitis	0.0006	0.000992	CcSEcCtD
Dexmedetomidine—Nausea—Mometasone—atopic dermatitis	0.0006	0.000992	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000598	0.000988	CcSEcCtD
Dexmedetomidine—Arrhythmia—Triamcinolone—atopic dermatitis	0.000594	0.000982	CcSEcCtD
Dexmedetomidine—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000592	0.000979	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Prednisone—atopic dermatitis	0.000592	0.000978	CcSEcCtD
Dexmedetomidine—Visual impairment—Betamethasone—atopic dermatitis	0.000581	0.000961	CcSEcCtD
Dexmedetomidine—Visual impairment—Dexamethasone—atopic dermatitis	0.000581	0.000961	CcSEcCtD
Dexmedetomidine—Mental disorder—Methylprednisolone—atopic dermatitis	0.000581	0.00096	CcSEcCtD
Dexmedetomidine—Malnutrition—Methylprednisolone—atopic dermatitis	0.000577	0.000954	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000577	0.000953	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Prednisone—atopic dermatitis	0.000573	0.000948	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Prednisone—atopic dermatitis	0.000573	0.000948	CcSEcCtD
Dexmedetomidine—Diarrhoea—Tacrolimus—atopic dermatitis	0.00055	0.000909	CcSEcCtD
Dexmedetomidine—Angiopathy—Betamethasone—atopic dermatitis	0.000547	0.000905	CcSEcCtD
Dexmedetomidine—Angiopathy—Dexamethasone—atopic dermatitis	0.000547	0.000905	CcSEcCtD
Dexmedetomidine—Convulsion—Prednisolone—atopic dermatitis	0.000545	0.000901	CcSEcCtD
Dexmedetomidine—Hypertension—Prednisolone—atopic dermatitis	0.000543	0.000898	CcSEcCtD
Dexmedetomidine—Arrhythmia—Dexamethasone—atopic dermatitis	0.000539	0.000891	CcSEcCtD
Dexmedetomidine—Arrhythmia—Betamethasone—atopic dermatitis	0.000539	0.000891	CcSEcCtD
Dexmedetomidine—Bradycardia—Prednisone—atopic dermatitis	0.000535	0.000884	CcSEcCtD
Dexmedetomidine—Convulsion—Hydrocortisone—atopic dermatitis	0.000532	0.00088	CcSEcCtD
Dexmedetomidine—Dizziness—Tacrolimus—atopic dermatitis	0.000531	0.000879	CcSEcCtD
Dexmedetomidine—Hypertension—Hydrocortisone—atopic dermatitis	0.00053	0.000877	CcSEcCtD
Dexmedetomidine—Haemoglobin—Prednisone—atopic dermatitis	0.000528	0.000873	CcSEcCtD
Dexmedetomidine—Haemorrhage—Prednisone—atopic dermatitis	0.000525	0.000868	CcSEcCtD
Dexmedetomidine—Hallucination—Prednisone—atopic dermatitis	0.000522	0.000864	CcSEcCtD
Dexmedetomidine—Anxiety—Hydrocortisone—atopic dermatitis	0.000521	0.000862	CcSEcCtD
Dexmedetomidine—Vomiting—Tacrolimus—atopic dermatitis	0.000511	0.000845	CcSEcCtD
Dexmedetomidine—Rash—Tacrolimus—atopic dermatitis	0.000507	0.000838	CcSEcCtD
Dexmedetomidine—Dermatitis—Tacrolimus—atopic dermatitis	0.000506	0.000837	CcSEcCtD
Dexmedetomidine—Headache—Tacrolimus—atopic dermatitis	0.000503	0.000833	CcSEcCtD
Dexmedetomidine—Convulsion—Triamcinolone—atopic dermatitis	0.000501	0.000829	CcSEcCtD
Dexmedetomidine—Tachycardia—Prednisolone—atopic dermatitis	0.000501	0.000828	CcSEcCtD
Dexmedetomidine—Convulsion—Methylprednisolone—atopic dermatitis	0.0005	0.000827	CcSEcCtD
Dexmedetomidine—Hypertension—Triamcinolone—atopic dermatitis	0.000499	0.000826	CcSEcCtD
Dexmedetomidine—Hypertension—Methylprednisolone—atopic dermatitis	0.000498	0.000824	CcSEcCtD
Dexmedetomidine—Infection—Hydrocortisone—atopic dermatitis	0.000498	0.000824	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000496	0.000821	CcSEcCtD
Dexmedetomidine—Anxiety—Methylprednisolone—atopic dermatitis	0.00049	0.00081	CcSEcCtD
Dexmedetomidine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000489	0.000809	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000485	0.000801	CcSEcCtD
Dexmedetomidine—Dry mouth—Triamcinolone—atopic dermatitis	0.000482	0.000796	CcSEcCtD
Dexmedetomidine—Nausea—Tacrolimus—atopic dermatitis	0.000477	0.000789	CcSEcCtD
Dexmedetomidine—Angiopathy—Prednisone—atopic dermatitis	0.000476	0.000788	CcSEcCtD
Dexmedetomidine—Confusional state—Methylprednisolone—atopic dermatitis	0.000475	0.000785	CcSEcCtD
Dexmedetomidine—Arrhythmia—Prednisone—atopic dermatitis	0.000469	0.000776	CcSEcCtD
Dexmedetomidine—Infection—Triamcinolone—atopic dermatitis	0.000469	0.000776	CcSEcCtD
Dexmedetomidine—Hypotension—Hydrocortisone—atopic dermatitis	0.000468	0.000775	CcSEcCtD
Dexmedetomidine—Infection—Methylprednisolone—atopic dermatitis	0.000468	0.000774	CcSEcCtD
Dexmedetomidine—Tachycardia—Triamcinolone—atopic dermatitis	0.000461	0.000762	CcSEcCtD
Dexmedetomidine—Mental disorder—Prednisone—atopic dermatitis	0.00046	0.000761	CcSEcCtD
Dexmedetomidine—Tachycardia—Methylprednisolone—atopic dermatitis	0.00046	0.00076	CcSEcCtD
Dexmedetomidine—Malnutrition—Prednisone—atopic dermatitis	0.000457	0.000756	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000456	0.000755	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000455	0.000753	CcSEcCtD
Dexmedetomidine—Convulsion—Betamethasone—atopic dermatitis	0.000455	0.000752	CcSEcCtD
Dexmedetomidine—Convulsion—Dexamethasone—atopic dermatitis	0.000455	0.000752	CcSEcCtD
Dexmedetomidine—Hypertension—Dexamethasone—atopic dermatitis	0.000453	0.000749	CcSEcCtD
Dexmedetomidine—Hypertension—Betamethasone—atopic dermatitis	0.000453	0.000749	CcSEcCtD
Dexmedetomidine—Anxiety—Dexamethasone—atopic dermatitis	0.000445	0.000736	CcSEcCtD
Dexmedetomidine—Anxiety—Betamethasone—atopic dermatitis	0.000445	0.000736	CcSEcCtD
Dexmedetomidine—Hypotension—Methylprednisolone—atopic dermatitis	0.00044	0.000728	CcSEcCtD
Dexmedetomidine—Pain—Prednisolone—atopic dermatitis	0.000439	0.000726	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000433	0.000716	CcSEcCtD
Dexmedetomidine—Pain—Hydrocortisone—atopic dermatitis	0.000429	0.000709	CcSEcCtD
Dexmedetomidine—Infection—Dexamethasone—atopic dermatitis	0.000426	0.000704	CcSEcCtD
Dexmedetomidine—Infection—Betamethasone—atopic dermatitis	0.000426	0.000704	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Prednisolone—atopic dermatitis	0.000423	0.0007	CcSEcCtD
Dexmedetomidine—Anaemia—Prednisone—atopic dermatitis	0.000422	0.000699	CcSEcCtD
Dexmedetomidine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000421	0.000696	CcSEcCtD
Dexmedetomidine—Agitation—Prednisone—atopic dermatitis	0.00042	0.000695	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000419	0.000694	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000419	0.000694	CcSEcCtD
Dexmedetomidine—Tachycardia—Dexamethasone—atopic dermatitis	0.000418	0.000691	CcSEcCtD
Dexmedetomidine—Tachycardia—Betamethasone—atopic dermatitis	0.000418	0.000691	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000414	0.000685	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000414	0.000685	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000413	0.000683	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.00041	0.000678	CcSEcCtD
Dexmedetomidine—Pain—Triamcinolone—atopic dermatitis	0.000404	0.000668	CcSEcCtD
Dexmedetomidine—Hypotension—Betamethasone—atopic dermatitis	0.0004	0.000662	CcSEcCtD
Dexmedetomidine—Hypotension—Dexamethasone—atopic dermatitis	0.0004	0.000662	CcSEcCtD
Dexmedetomidine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000396	0.000655	CcSEcCtD
Dexmedetomidine—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000396	0.000655	CcSEcCtD
Dexmedetomidine—Convulsion—Prednisone—atopic dermatitis	0.000396	0.000655	CcSEcCtD
Dexmedetomidine—Hypertension—Prednisone—atopic dermatitis	0.000395	0.000653	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000389	0.000643	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000388	0.000642	CcSEcCtD
Dexmedetomidine—Anxiety—Prednisone—atopic dermatitis	0.000388	0.000641	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000385	0.000637	CcSEcCtD
Dexmedetomidine—Body temperature increased—Triamcinolone—atopic dermatitis	0.000373	0.000617	CcSEcCtD
Dexmedetomidine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000372	0.000616	CcSEcCtD
Dexmedetomidine—Infection—Prednisone—atopic dermatitis	0.000371	0.000613	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.00037	0.000612	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.00037	0.000612	CcSEcCtD
Dexmedetomidine—Pain—Dexamethasone—atopic dermatitis	0.000366	0.000606	CcSEcCtD
Dexmedetomidine—Pain—Betamethasone—atopic dermatitis	0.000366	0.000606	CcSEcCtD
Dexmedetomidine—Tachycardia—Prednisone—atopic dermatitis	0.000364	0.000602	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Prednisone—atopic dermatitis	0.000361	0.000596	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Betamethasone—atopic dermatitis	0.000353	0.000584	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000353	0.000584	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.00035	0.000579	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.00035	0.000579	CcSEcCtD
Dexmedetomidine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000343	0.000567	CcSEcCtD
Dexmedetomidine—Dizziness—Prednisolone—atopic dermatitis	0.000339	0.000561	CcSEcCtD
Dexmedetomidine—Body temperature increased—Betamethasone—atopic dermatitis	0.000339	0.00056	CcSEcCtD
Dexmedetomidine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000339	0.00056	CcSEcCtD
Dexmedetomidine—Abdominal pain—Betamethasone—atopic dermatitis	0.000339	0.00056	CcSEcCtD
Dexmedetomidine—Body temperature increased—Dexamethasone—atopic dermatitis	0.000339	0.00056	CcSEcCtD
Dexmedetomidine—Dizziness—Hydrocortisone—atopic dermatitis	0.000332	0.000548	CcSEcCtD
Dexmedetomidine—Rash—Prednisolone—atopic dermatitis	0.000324	0.000535	CcSEcCtD
Dexmedetomidine—Dermatitis—Prednisolone—atopic dermatitis	0.000323	0.000535	CcSEcCtD
Dexmedetomidine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000322	0.000533	CcSEcCtD
Dexmedetomidine—Headache—Prednisolone—atopic dermatitis	0.000322	0.000532	CcSEcCtD
Dexmedetomidine—Constipation—Prednisone—atopic dermatitis	0.000319	0.000527	CcSEcCtD
Dexmedetomidine—Vomiting—Hydrocortisone—atopic dermatitis	0.000319	0.000527	CcSEcCtD
Dexmedetomidine—Rash—Hydrocortisone—atopic dermatitis	0.000316	0.000523	CcSEcCtD
Dexmedetomidine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000316	0.000522	CcSEcCtD
Dexmedetomidine—Headache—Hydrocortisone—atopic dermatitis	0.000314	0.000519	CcSEcCtD
Dexmedetomidine—Dizziness—Triamcinolone—atopic dermatitis	0.000312	0.000516	CcSEcCtD
Dexmedetomidine—Dizziness—Methylprednisolone—atopic dermatitis	0.000311	0.000515	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Prednisone—atopic dermatitis	0.000307	0.000508	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000305	0.000504	CcSEcCtD
Dexmedetomidine—Nausea—Prednisolone—atopic dermatitis	0.000305	0.000504	CcSEcCtD
Dexmedetomidine—Vomiting—Triamcinolone—atopic dermatitis	0.0003	0.000496	CcSEcCtD
Dexmedetomidine—Vomiting—Methylprednisolone—atopic dermatitis	0.000299	0.000495	CcSEcCtD
Dexmedetomidine—Nausea—Hydrocortisone—atopic dermatitis	0.000298	0.000492	CcSEcCtD
Dexmedetomidine—Rash—Triamcinolone—atopic dermatitis	0.000298	0.000492	CcSEcCtD
Dexmedetomidine—Dermatitis—Triamcinolone—atopic dermatitis	0.000297	0.000492	CcSEcCtD
Dexmedetomidine—Rash—Methylprednisolone—atopic dermatitis	0.000297	0.000491	CcSEcCtD
Dexmedetomidine—Dermatitis—Methylprednisolone—atopic dermatitis	0.000297	0.000491	CcSEcCtD
Dexmedetomidine—Headache—Triamcinolone—atopic dermatitis	0.000296	0.000489	CcSEcCtD
Dexmedetomidine—Headache—Methylprednisolone—atopic dermatitis	0.000295	0.000488	CcSEcCtD
Dexmedetomidine—Abdominal pain—Prednisone—atopic dermatitis	0.000295	0.000488	CcSEcCtD
Dexmedetomidine—Body temperature increased—Prednisone—atopic dermatitis	0.000295	0.000488	CcSEcCtD
Dexmedetomidine—Diarrhoea—Betamethasone—atopic dermatitis	0.000293	0.000485	CcSEcCtD
Dexmedetomidine—Diarrhoea—Dexamethasone—atopic dermatitis	0.000293	0.000485	CcSEcCtD
Dexmedetomidine—Dizziness—Dexamethasone—atopic dermatitis	0.000283	0.000468	CcSEcCtD
Dexmedetomidine—Dizziness—Betamethasone—atopic dermatitis	0.000283	0.000468	CcSEcCtD
Dexmedetomidine—Nausea—Triamcinolone—atopic dermatitis	0.00028	0.000464	CcSEcCtD
Dexmedetomidine—Nausea—Methylprednisolone—atopic dermatitis	0.00028	0.000463	CcSEcCtD
Dexmedetomidine—Vomiting—Betamethasone—atopic dermatitis	0.000272	0.00045	CcSEcCtD
Dexmedetomidine—Vomiting—Dexamethasone—atopic dermatitis	0.000272	0.00045	CcSEcCtD
Dexmedetomidine—Rash—Dexamethasone—atopic dermatitis	0.00027	0.000447	CcSEcCtD
Dexmedetomidine—Rash—Betamethasone—atopic dermatitis	0.00027	0.000447	CcSEcCtD
Dexmedetomidine—Dermatitis—Betamethasone—atopic dermatitis	0.00027	0.000446	CcSEcCtD
Dexmedetomidine—Dermatitis—Dexamethasone—atopic dermatitis	0.00027	0.000446	CcSEcCtD
Dexmedetomidine—Headache—Betamethasone—atopic dermatitis	0.000268	0.000444	CcSEcCtD
Dexmedetomidine—Headache—Dexamethasone—atopic dermatitis	0.000268	0.000444	CcSEcCtD
Dexmedetomidine—Diarrhoea—Prednisone—atopic dermatitis	0.000255	0.000422	CcSEcCtD
Dexmedetomidine—Nausea—Dexamethasone—atopic dermatitis	0.000254	0.000421	CcSEcCtD
Dexmedetomidine—Nausea—Betamethasone—atopic dermatitis	0.000254	0.000421	CcSEcCtD
Dexmedetomidine—Dizziness—Prednisone—atopic dermatitis	0.000247	0.000408	CcSEcCtD
Dexmedetomidine—Vomiting—Prednisone—atopic dermatitis	0.000237	0.000392	CcSEcCtD
Dexmedetomidine—Rash—Prednisone—atopic dermatitis	0.000235	0.000389	CcSEcCtD
Dexmedetomidine—Dermatitis—Prednisone—atopic dermatitis	0.000235	0.000389	CcSEcCtD
Dexmedetomidine—Headache—Prednisone—atopic dermatitis	0.000234	0.000386	CcSEcCtD
Dexmedetomidine—Nausea—Prednisone—atopic dermatitis	0.000222	0.000366	CcSEcCtD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—CXCR3—atopic dermatitis	4.48e-05	0.00157	CbGpPWpGaD
Dexmedetomidine—ADRA2B—G alpha (i) signalling events—CXCL8—atopic dermatitis	4.48e-05	0.00157	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.47e-05	0.00157	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL22—atopic dermatitis	4.42e-05	0.00155	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—CXCL10—atopic dermatitis	4.39e-05	0.00154	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL22—atopic dermatitis	4.35e-05	0.00152	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CCR3—atopic dermatitis	4.33e-05	0.00152	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—ADSL—atopic dermatitis	4.31e-05	0.00151	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CCR3—atopic dermatitis	4.26e-05	0.00149	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—IL5—atopic dermatitis	4.25e-05	0.00149	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCL27—atopic dermatitis	4.22e-05	0.00148	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CCR3—atopic dermatitis	4.21e-05	0.00147	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	4.2e-05	0.00147	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—CCR5—atopic dermatitis	4.19e-05	0.00147	CbGpPWpGaD
Dexmedetomidine—ADRA2C—G alpha (i) signalling events—CXCL8—atopic dermatitis	4.19e-05	0.00147	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCL17—atopic dermatitis	4.19e-05	0.00147	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—TAC1—atopic dermatitis	4.15e-05	0.00145	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—NPS—atopic dermatitis	4.15e-05	0.00145	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—CCR5—atopic dermatitis	4.13e-05	0.00145	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—TAC1—atopic dermatitis	4.13e-05	0.00145	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—NPS—atopic dermatitis	4.13e-05	0.00145	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—CXCR3—atopic dermatitis	4.07e-05	0.00143	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—CXCR3—atopic dermatitis	4.05e-05	0.00142	CbGpPWpGaD
Dexmedetomidine—SLC6A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.97e-05	0.00139	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.95e-05	0.00138	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL27—atopic dermatitis	3.94e-05	0.00138	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CCR3—atopic dermatitis	3.93e-05	0.00138	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CCL11—atopic dermatitis	3.91e-05	0.00137	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL27—atopic dermatitis	3.88e-05	0.00136	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CCR3—atopic dermatitis	3.87e-05	0.00135	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL5—atopic dermatitis	3.86e-05	0.00135	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—FCER2—atopic dermatitis	3.86e-05	0.00135	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—TAC1—atopic dermatitis	3.86e-05	0.00135	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—NPS—atopic dermatitis	3.86e-05	0.00135	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—IL5—atopic dermatitis	3.84e-05	0.00134	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—TAC1—atopic dermatitis	3.79e-05	0.00133	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—NPS—atopic dermatitis	3.79e-05	0.00133	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—CCL5—atopic dermatitis	3.78e-05	0.00132	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CXCR3—atopic dermatitis	3.78e-05	0.00132	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCL17—atopic dermatitis	3.78e-05	0.00132	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—NPS—atopic dermatitis	3.75e-05	0.00131	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—TAC1—atopic dermatitis	3.75e-05	0.00131	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—KIF3A—atopic dermatitis	3.73e-05	0.00131	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CXCR3—atopic dermatitis	3.72e-05	0.0013	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CXCR3—atopic dermatitis	3.68e-05	0.00129	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—GLB1—atopic dermatitis	3.65e-05	0.00128	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—CXCL10—atopic dermatitis	3.62e-05	0.00127	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL22—atopic dermatitis	3.59e-05	0.00126	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—IL5—atopic dermatitis	3.58e-05	0.00126	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.57e-05	0.00125	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL17—atopic dermatitis	3.53e-05	0.00124	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—IL5—atopic dermatitis	3.53e-05	0.00124	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CCR3—atopic dermatitis	3.51e-05	0.00123	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—NPS—atopic dermatitis	3.5e-05	0.00123	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—TAC1—atopic dermatitis	3.5e-05	0.00123	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ADSL—atopic dermatitis	3.5e-05	0.00123	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL5—atopic dermatitis	3.48e-05	0.00122	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL17—atopic dermatitis	3.48e-05	0.00122	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—NPS—atopic dermatitis	3.45e-05	0.00121	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—TAC1—atopic dermatitis	3.45e-05	0.00121	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CXCR3—atopic dermatitis	3.43e-05	0.0012	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	3.41e-05	0.0012	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—CCR5—atopic dermatitis	3.41e-05	0.00119	CbGpPWpGaD
Dexmedetomidine—ADRA2A—G alpha (i) signalling events—CXCL8—atopic dermatitis	3.4e-05	0.00119	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CXCR3—atopic dermatitis	3.38e-05	0.00118	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCL11—atopic dermatitis	3.38e-05	0.00118	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CMA1—atopic dermatitis	3.38e-05	0.00118	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—KIF3A—atopic dermatitis	3.37e-05	0.00118	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—GLB1—atopic dermatitis	3.35e-05	0.00117	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.33e-05	0.00117	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—CXCL10—atopic dermatitis	3.29e-05	0.00115	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.28e-05	0.00115	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—CXCL10—atopic dermatitis	3.27e-05	0.00115	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL5—atopic dermatitis	3.26e-05	0.00114	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ADSL—atopic dermatitis	3.21e-05	0.00113	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL5—atopic dermatitis	3.2e-05	0.00112	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL27—atopic dermatitis	3.2e-05	0.00112	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CCR3—atopic dermatitis	3.19e-05	0.00112	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—STAT6—atopic dermatitis	3.17e-05	0.00111	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—GLB1—atopic dermatitis	3.16e-05	0.00111	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—KIF3A—atopic dermatitis	3.15e-05	0.0011	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—NPS—atopic dermatitis	3.13e-05	0.0011	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—TAC1—atopic dermatitis	3.13e-05	0.0011	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—CCL5—atopic dermatitis	3.12e-05	0.00109	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—KIF3A—atopic dermatitis	3.1e-05	0.00109	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	3.07e-05	0.00108	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CXCL10—atopic dermatitis	3.06e-05	0.00107	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CMA1—atopic dermatitis	3.05e-05	0.00107	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCL11—atopic dermatitis	3.05e-05	0.00107	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ADSL—atopic dermatitis	3.03e-05	0.00106	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CXCL10—atopic dermatitis	3.01e-05	0.00105	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR ligand binding—CXCL8—atopic dermatitis	3.01e-05	0.00105	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3e-05	0.00105	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CXCL10—atopic dermatitis	2.97e-05	0.00104	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—IL5—atopic dermatitis	2.91e-05	0.00102	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL17—atopic dermatitis	2.87e-05	0.001	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—STAT6—atopic dermatitis	2.87e-05	0.001	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL11—atopic dermatitis	2.85e-05	0.000997	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CMA1—atopic dermatitis	2.85e-05	0.000997	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—TAC1—atopic dermatitis	2.84e-05	0.000996	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—NPS—atopic dermatitis	2.84e-05	0.000996	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—CCL5—atopic dermatitis	2.83e-05	0.000992	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—CCL5—atopic dermatitis	2.82e-05	0.000987	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—CCR5—atopic dermatitis	2.81e-05	0.000985	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL11—atopic dermatitis	2.8e-05	0.000981	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CMA1—atopic dermatitis	2.8e-05	0.000981	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CXCR3—atopic dermatitis	2.79e-05	0.000977	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CXCL10—atopic dermatitis	2.78e-05	0.000972	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCR3—atopic dermatitis	2.75e-05	0.000964	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CXCL10—atopic dermatitis	2.73e-05	0.000957	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—CXCL8—atopic dermatitis	2.71e-05	0.000951	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.7e-05	0.000948	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—STAT6—atopic dermatitis	2.68e-05	0.000938	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL5—atopic dermatitis	2.64e-05	0.000926	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—STAT6—atopic dermatitis	2.63e-05	0.000923	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CCL5—atopic dermatitis	2.63e-05	0.000922	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CCL5—atopic dermatitis	2.59e-05	0.000907	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CCL5—atopic dermatitis	2.56e-05	0.000896	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—KIF3A—atopic dermatitis	2.56e-05	0.000896	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—CCR5—atopic dermatitis	2.55e-05	0.000894	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—CCR5—atopic dermatitis	2.54e-05	0.000889	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—CXCL8—atopic dermatitis	2.54e-05	0.000888	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—CXCL8—atopic dermatitis	2.5e-05	0.000874	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.49e-05	0.000871	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCR3—atopic dermatitis	2.48e-05	0.00087	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	2.48e-05	0.00087	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NPS—atopic dermatitis	2.45e-05	0.000859	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TAC1—atopic dermatitis	2.45e-05	0.000859	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CXCR3—atopic dermatitis	2.41e-05	0.000843	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CCL5—atopic dermatitis	2.39e-05	0.000837	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GLB1—atopic dermatitis	2.38e-05	0.000833	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CCR5—atopic dermatitis	2.37e-05	0.00083	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CCL5—atopic dermatitis	2.35e-05	0.000824	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CCR5—atopic dermatitis	2.33e-05	0.000817	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCR3—atopic dermatitis	2.32e-05	0.000813	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—IL2—atopic dermatitis	2.32e-05	0.000813	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CMA1—atopic dermatitis	2.31e-05	0.00081	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL11—atopic dermatitis	2.31e-05	0.00081	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CCR5—atopic dermatitis	2.3e-05	0.000807	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.3e-05	0.000806	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCR3—atopic dermatitis	2.28e-05	0.0008	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL5—atopic dermatitis	2.28e-05	0.000799	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ADSL—atopic dermatitis	2.28e-05	0.000799	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CXCL10—atopic dermatitis	2.25e-05	0.00079	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NPS—atopic dermatitis	2.21e-05	0.000776	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TAC1—atopic dermatitis	2.21e-05	0.000776	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—STAT6—atopic dermatitis	2.17e-05	0.000762	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CXCR3—atopic dermatitis	2.17e-05	0.000761	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—IL2—atopic dermatitis	2.17e-05	0.000759	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CCR5—atopic dermatitis	2.15e-05	0.000754	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CCL5—atopic dermatitis	2.14e-05	0.000749	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CCR5—atopic dermatitis	2.12e-05	0.000742	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TAC1—atopic dermatitis	2.07e-05	0.000725	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NPS—atopic dermatitis	2.07e-05	0.000725	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	2.06e-05	0.000722	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL5—atopic dermatitis	2.06e-05	0.000721	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NPS—atopic dermatitis	2.04e-05	0.000713	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TAC1—atopic dermatitis	2.04e-05	0.000713	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CXCR3—atopic dermatitis	2.03e-05	0.000711	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GLB1—atopic dermatitis	2.01e-05	0.000706	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CXCR3—atopic dermatitis	2e-05	0.000699	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CXCL10—atopic dermatitis	1.94e-05	0.000681	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	1.94e-05	0.00068	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.93e-05	0.000677	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	1.93e-05	0.000674	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL5—atopic dermatitis	1.92e-05	0.000674	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL5—atopic dermatitis	1.89e-05	0.000663	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	1.89e-05	0.00066	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—IL2—atopic dermatitis	1.76e-05	0.000617	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CXCL10—atopic dermatitis	1.76e-05	0.000615	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	1.75e-05	0.000612	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.7e-05	0.000595	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	1.68e-05	0.000589	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	1.68e-05	0.000589	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCL5—atopic dermatitis	1.67e-05	0.000586	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	1.65e-05	0.000577	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	1.64e-05	0.000574	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—IL2—atopic dermatitis	1.62e-05	0.000569	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	1.61e-05	0.000565	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	1.56e-05	0.000547	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NGF—atopic dermatitis	1.55e-05	0.000543	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.54e-05	0.000541	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.53e-05	0.000537	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	1.51e-05	0.000529	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCR5—atopic dermatitis	1.51e-05	0.000528	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL2—atopic dermatitis	1.47e-05	0.000517	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.47e-05	0.000514	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	1.47e-05	0.000514	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PPARA—atopic dermatitis	1.46e-05	0.000511	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	1.43e-05	0.000502	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	1.41e-05	0.000494	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.41e-05	0.000494	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	1.4e-05	0.00049	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	1.39e-05	0.000488	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	1.39e-05	0.000487	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	1.37e-05	0.00048	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	1.36e-05	0.000477	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	1.35e-05	0.000472	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	1.33e-05	0.000467	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	1.33e-05	0.000466	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	1.31e-05	0.000458	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	1.3e-05	0.000456	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	1.29e-05	0.000451	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.28e-05	0.000449	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NFKBIA—atopic dermatitis	1.28e-05	0.000448	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	1.27e-05	0.000445	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	1.25e-05	0.000438	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	1.24e-05	0.000436	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	1.22e-05	0.000429	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PPARA—atopic dermatitis	1.18e-05	0.000415	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.16e-05	0.000408	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	1.15e-05	0.000404	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	1.15e-05	0.000402	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	1.11e-05	0.00039	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PPARA—atopic dermatitis	1.09e-05	0.000381	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	1.08e-05	0.000378	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	1.06e-05	0.000372	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	1.06e-05	0.000372	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	1.06e-05	0.00037	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	1.03e-05	0.000362	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PPARA—atopic dermatitis	1.03e-05	0.000359	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	1.01e-05	0.000354	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CXCL8—atopic dermatitis	9.12e-06	0.000319	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	8.76e-06	0.000307	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL2—atopic dermatitis	8.71e-06	0.000305	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL6—atopic dermatitis	8.67e-06	0.000304	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	8.23e-06	0.000288	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MAPK8—atopic dermatitis	8.02e-06	0.000281	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	7.87e-06	0.000276	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	7.83e-06	0.000274	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPARA—atopic dermatitis	7.72e-06	0.00027	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	7.69e-06	0.000269	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	7.57e-06	0.000265	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	7.35e-06	0.000257	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	7.31e-06	0.000256	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	7.24e-06	0.000254	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	7.23e-06	0.000253	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	7.19e-06	0.000252	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	6.76e-06	0.000237	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	6.66e-06	0.000233	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPARA—atopic dermatitis	6.54e-06	0.000229	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	6.24e-06	0.000219	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	5.97e-06	0.000209	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	5.94e-06	0.000208	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	5.49e-06	0.000192	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL6—atopic dermatitis	5.12e-06	0.000179	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	4.62e-06	0.000162	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	4.32e-06	0.000151	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	4.25e-06	0.000149	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	3.51e-06	0.000123	CbGpPWpGaD
